In the last years, the development of nano-formulations for cancer treatment represents one of the majorchallenges of the scientific research. The prodrug strategy, that combines chemotherapeutic agents withnanocarriers such as halloysite nanotubes (HNTs), is a promising strategy both to improve the biologicalactivity of the drug molecules and to reduce the side effects of drugs. Herein we report the synthesis andcharacterization of a HNTs prodrug based on 1,2,3-triazole units covalently linked to HNTs external surface,bearing different positively charged moieties, which could present interesting pharmacological activities.
1,2,3-Oligotriazoles modified halloysite nanotubes as potential active biological species: synthesis and characterization
Riela, Serena;
2022-01-01
Abstract
In the last years, the development of nano-formulations for cancer treatment represents one of the majorchallenges of the scientific research. The prodrug strategy, that combines chemotherapeutic agents withnanocarriers such as halloysite nanotubes (HNTs), is a promising strategy both to improve the biologicalactivity of the drug molecules and to reduce the side effects of drugs. Herein we report the synthesis andcharacterization of a HNTs prodrug based on 1,2,3-triazole units covalently linked to HNTs external surface,bearing different positively charged moieties, which could present interesting pharmacological activities.File | Dimensione | Formato | |
---|---|---|---|
2022 ARKIVOC Allosite.pdf
accesso aperto
Tipologia:
Documento in Post-print
Licenza:
Creative commons
Dimensione
603.81 kB
Formato
Adobe PDF
|
603.81 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.